Logomix is a pioneering synthetic biology company. With its unprecedented genome engineering platform, Geno-Writing™, Logomix facilitates precise and Mb-scale manipulation of genomic sequences within human cells, leads the development of super-functionalized hypoimmune cells to address critical limitations in contemporary cell therapy approaches, and unlocks the potential with a TAM of solid tumors and 70,000 genetic diseases worth trillion of dollars.
DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.
Carbon Biosciences develops genetic medicines for the treatment of devastating diseases. They develop their vector using industrial-scale viral production platforms and can be used to deliver a wide-range of therapeutic modalities.
Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus is comprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms.
Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System (CNS) Therapeutics to improve the quality of life for people with CNS diseases and disorders.
TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.
VividQ is bringing about a revolution in digital display and creating the human-machine interface for the next generation of consumer devices. VividQ's computational display technology is creating a future where 3D holographic images are cast into our everyday environment, removing the screens that separate our real and virtual experiences. The company partners with leading original electronics manufacturers (OEMs) to integrate its advanced software and hardware solutions into augmented reality (AR), virtual reality (VR), automotive head-up displays, and other consumer electronics. Founded in 2017, the company is based in Cambridge, U.K., with partners and teams in the U.S. and Japan.
Telexistence aims to be the systematic innovator of scale in robotics. Innovator means new stuff. And scale means big, systematic ways of looking at things done in a way that’s reproducible.
Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.
In Sonas, "UNISONet" is being developed from the viewpoint that "In order to truly become a cornerstone of society, IoT needs to realize high quality wireless sensing." By adopting the latest technology which is totally different from the currently popular mesh network technology called simultaneous transmission flooding, power saving, multihop, time synchronization, lossless data collection, high speed acquisition, low delay Bidirectional communication, etc., "all at the same time" are realized.
ARAV offers solutions for construction site problems updating the site. The company works to ensure on-site safety and reduce risks as soon as possible around the world. Control construction equipment remotely via the internet. Compatible with smartphones, tablets, digging, cutting, and putting to the truck, and person detection.
RIN Institute is a bio-venture firm dedicated to the research and development of antibody-based medicines and external diagnostic drugs.
HarvestX began as a basic notion to adapt robot technology to agriculture at the Hongo Tech Garage, a project area for students at the University of Tokyo. The company discovered the potential of indoor vertical farms for producing fruits through multiple conversations with indoor vertical farms and food manufacturers, as well as various trials. The company concentrated on constructing an automated pollination robot, which is a big difficulty in fruit cultivation.
Urban X Technologies' service supports inspection of the road conditions. AI technology-based inspection enables to detect the damage of the road and send an alert to investigator. This gives more efficient way of inspection rather than relying on visual confirmation by an investigator for any damages on the road.
BionicM develops high-performance robot prostheses that enhance mobility for people with disabilities. BionicM has been conducting research on innovative technologies since 2015 at the University of Tokyo's Information Systems Engineering Laboratory (JSK) under the guidance of Professor Inaba and utilizing the world's most advanced robotics research. In 2016, we were adopted by the Japan Science and Technology Agency as part of "Program for Creating STart-ups from Advanced Research and Technology" (START), and in 2018, the company was established as a joint-stock company.
Planning, research and development, designing, manufacturing and distribution of medical device and healthcare devices. Consulting service in management and strategy on technology in medical device field. Supporting research and development processes.
Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology.
FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The human body is comprised of at least 18,097 proteins.It has been revealed that 1,500 of them are related to certain diseases, nevertheless only about 300 proteins have been regarded as druggable targets by small molecule drug discovery and all the rest have been undruggable.
Onedot offers apps and platforms for the diverse need of their customers. Babily, PetNote, LadyX, and MN Consulting Room are a few of the company's apps. Babily is a parenting video platform, PetNote is an app for pet health, LadyX is a business platform for beauty and health, and MN Consulting Room is a medical platform for travelers to Japan. Onedot additionally aids in the advancement of Chinese digital business plans.
Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus is comprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms.
TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.
Aidemy is a web service where users can learn AI programming online. Aidemy offers all-in-one teaching materials as well as a programming execution environment. Aidemy implements cutting-edge technology and offers support from DX human resource development centered on AI to actual operation.
AccRna, Inc.'s aim is to promote therapeutic innovation in the form of nucleic acid medicine utilizing our robust DDS platform, providing effective treatment for refractory diseases for which there is currently no cure. Our dream is to deliver a “radical cure” to patients suffering from refractory diseases all over the world by safely and efficiently achieving the ultimate in the therapy utilizing nucleic acid.
WealthNavi offers a platform for asset managers which uses risk management algorithm for asset management advice.
Synspective provides SAR data and remote monitoring services to government agencies. Its satellite data technology utilizes and integrates data from satellite constellations, big data, and machine learning. It provides various satellite services, including remote sensing and satellite imagery using small-sized SAR satellites that can measure human activity over a wide area on earth, regardless of time or weather.
Connected Robotics is an information technology company that designs and manufactures robotic arms for enterprises. The company's product, OctoChef, provides cooking services. It caters to individual restaurants, shopping malls, stations, service areas, amusement centers, and large-scale events. The company was founded in 2014 and is based in Koganei-shi, Japan.
Astroscale is one of the few companies in the world proposing to aid in the removal of orbital debris through the provision of end-of-life (EOL) and active debris removal (ADR) services. In addition to providing a technical solution, Astroscale is helping to define the business case for this service and is working with national space agencies, international institutions, non-profit organizations, insurance companies, and satellite operators to develop norms, regulations, and incentives that contribute to the responsible use of space.
EdiGENE Inc. is a biotechnology company that specializes in developing therapeutics for genetic disorders. Founded in 2016 and headquartered in Tokyo, Japan, with additional offices in Cambridge, Massachusetts, the company leverages its proprietary technologies, including clustered regularly interspaced short palindromic repeats (CRISPR) and guide nucleotide directed modulation (GNDM), to create innovative treatments. EdiGENE's focus is on addressing unmet medical needs through its advanced therapeutic solutions, supported by a strong foundation of intellectual property licensed from the University of Tokyo.
QD Laser is a developer of quantum dot laser technology designed to offer high performance semiconductor lasers.The company's quantum dot laser technology develops new semiconductor lasers in a wide range of fields and offer current-free quantum dot lasers for communications, enabling telecommunication industries to get services that helps them improve their businesses.
CREWT Medical Systems, Inc. developed world first head-mounted perimeter, compatible standard automated perimeter, based on our cutting edge lens designing techniques and software engineering that meets the needs of the clinical site. The company name “CREWT” is an acronym for “CREation” “Weave” “Technologies“. We aims to create “new value” by weaving up the existing excellent technology in the world. We will continue to make effort to create and provide human-centric medical devices for a better Quality Of Vision. Our mission is to ‘CRE’ate new values by ‘W’eaving up existing ‘T’echnologies, acronymized as “CREWT”.
Astroscale is one of the few companies in the world proposing to aid in the removal of orbital debris through the provision of end-of-life (EOL) and active debris removal (ADR) services. In addition to providing a technical solution, Astroscale is helping to define the business case for this service and is working with national space agencies, international institutions, non-profit organizations, insurance companies, and satellite operators to develop norms, regulations, and incentives that contribute to the responsible use of space.
Axelspace is a startup company developing businesses in the microsatellite field. Axelspace plans to construct a monitoring platform to cover the entire globe on a daily basis at extremely low cost.
Synspective provides SAR data and remote monitoring services to government agencies. Its satellite data technology utilizes and integrates data from satellite constellations, big data, and machine learning. It provides various satellite services, including remote sensing and satellite imagery using small-sized SAR satellites that can measure human activity over a wide area on earth, regardless of time or weather.
Telexistence aims to be the systematic innovator of scale in robotics. Innovator means new stuff. And scale means big, systematic ways of looking at things done in a way that’s reproducible.
QD Laser is a developer of quantum dot laser technology designed to offer high performance semiconductor lasers.The company's quantum dot laser technology develops new semiconductor lasers in a wide range of fields and offer current-free quantum dot lasers for communications, enabling telecommunication industries to get services that helps them improve their businesses.
Braizon Therapeutics, Inc. was established with the aim of applying and implementing, within the fields of medicine and life science, innovative technology for the delivery of drugs to the brain as the outcome of collaborative research by Professor Kazunori Kataoka from the Graduate School of Engineering/Medicine, the University of Tokyo and Professor Takanori Yokota from the Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.
TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.
AccRna, Inc.'s aim is to promote therapeutic innovation in the form of nucleic acid medicine utilizing our robust DDS platform, providing effective treatment for refractory diseases for which there is currently no cure. Our dream is to deliver a “radical cure” to patients suffering from refractory diseases all over the world by safely and efficiently achieving the ultimate in the therapy utilizing nucleic acid.
Alivas is a medical company that develops new therapeutic medical devices for refractory constipation. It is a joint venture between Stanford University and the University of Tokyo with the Japan Biodesign program for innovative medical device creation. The company was founded in 2017 and is based in Hongo, Tokyo in Japan.
Xenoma Inc. is a spin-off company from Someya Group Organic Transistor Lab in the University of T[okyo and JST/ERATO Someya Bio-Harmonized Electronics Project. Professor Takao Someya have been dealing with Organic Electronics since 2003. His ultrathin and ultraflexible device is harmoniously interface with human bodies by taking advantage of the inherent softness of organic materials. Xenoma is aiming at realizing e-skin, which is a next-generation textile-based wearable electronics as an ideal interface between human and device.
CREWT Medical Systems, Inc. developed world first head-mounted perimeter, compatible standard automated perimeter, based on our cutting edge lens designing techniques and software engineering that meets the needs of the clinical site. The company name “CREWT” is an acronym for “CREation” “Weave” “Technologies“. We aims to create “new value” by weaving up the existing excellent technology in the world. We will continue to make effort to create and provide human-centric medical devices for a better Quality Of Vision. Our mission is to ‘CRE’ate new values by ‘W’eaving up existing ‘T’echnologies, acronymized as “CREWT”.